Navigation Links
Novavax Reports Second Quarter 2009 Financial Results
Date:8/7/2009

9,814 General and administrative 2,562 3,166 5,454 6,410 ----- ----- ----- ----- Total operating costs and expenses 7,859 8,546 15,017 16,224 ----- ----- ------ ------ Loss from continuing operations before other (expense) income, net (7,830) (8,204) (14,967) (15,424) Other (expense) income, net (710) (110) (1,922) 7 ---- ---- ------ -- Loss from continuing operations (8,540) (8,314) (16,889) (15,417) Loss from discontinued operations - (1,058) - (1,710) -- ------ -- ------ Net loss $(8,540) $(9,372) $(16,889) $(17,127) ======= ======= ======== ======== Basic and diluted net loss per share: Loss per share from continuing operations $(0.10) $(0.14) $(0.22) $(0.25) Loss per share from discontinued operations - $(0.02) - $(0.03) Net loss per share $(0.10) $(0.15) $(0.22) $(0.28) Basic and diluted weighted average number of common shares outstanding 84,832,226 61,329,699 76,806,926 61,286,169 ========== ========== ========== ========== SELECTED BALANCE SHEET DATA (in thousands) As of June 30, As of December 31, 2009 2008 ----
'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
2. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
3. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
4. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
5. Novavax Announces Repayment of $5 Million of Convertible Debt
6. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
7. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
8. Novavax Appoints Stanley Erck to Board of Directors
9. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
10. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2009
11. Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... 2015 The fully automated supercritical ... can sequentially analyze up to 48 samples utilizing ... detection of targets by mass spectrometry. , ... the measurement requirements of a wide range of ... delivery and search for disease biomarkers, additives in ...
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5
... , , ROCKVILLE, Md., July 22 ... announced that the U.S. Government has exercised its option to purchase ... Stockpile, to be delivered over a three-year period, beginning near the ... from this award as deliveries are completed. , ...
... ... projects now face critical challenge of cutting costs. According to Top Phycologist Dr. Mario ... at Algae World, Prof. Tredici shared his innovative research on Algae projects with Algae ... ...
... , ROCKVILLE, Md., July 21 Novavax, ... of John J. Trizzino as Senior Vice President, International and ... will report directly to Dr. Rahul Singhvi, Novavax,s President and ... the company,s international alliances with pharmaceutical companies and all governmental ...
Cached Biology Technology:Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 2Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 3Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 4Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 5Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government 6Prof. Mario Tredici Shared Views on Algae Projects with Algae Business Players at Algae World! 2Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances 2
(Date:2/24/2015)... , Feb. 24, 2015 Research and Markets ... addition of the "Global 2D Gesture Recognition ... The analysts forecast the Global 2D ... of 32.12% over the period 2014-2019 ... non-traditional sectors is one of the major trends ...
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... filed provisional patent 62/113114 for DISTRIBUTED METHOD ... The patent further establishes NXT-ID,s position in ... intellectual property portfolio the ability for multiple devices to ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... million tons of rubber are processed and a large portion ... the products reach the end of their useful life, they ... waste rubber is recycled into secondary products. Ground to powder, ... floor coverings used at sports arenas and playgrounds, and in ...
... nano building materials is on the way to creating ... and electronics., The idea of using artificial DNA strands ... scientists in the 1990s, and the continued development has ... However, during the last decade European researchers have contributed ...
... five-year, $5 million grant from the National Cancer Institute that ... breast cancer survivors likely to suffer from depression. UCLA ... the 300 volunteers needed for the study by culling through ... for breast cancer and don,t have a history of depression. ...
Cached Biology News:Quality products from rubber residues 2Quality products from rubber residues 3European boost for DNA nanotechnology 2European boost for DNA nanotechnology 3UCLA researchers to study depression in breast cancer survivors 2UCLA researchers to study depression in breast cancer survivors 3
Mouse monoclonal antibody raised against a partial recombinant PUM2. NCBI Entrez Gene ID = PUM2...
... Cloning Kit enables you to prepare, in ... primary cosmid library of genomic DNA for ... High efficiency cosmid library construction is accomplished ... First, genomic DNA is randomly sheared by ...
... Disposable. Virgin, optically clear polystyrene ... and alphanumeric coordinates for cell counting. ... number is a new product number, ... number. If showing no availability yet, ...
Mouse monoclonal antibody raised against a partial recombinant AATK. NCBI Entrez Gene ID = AATK...
Biology Products: